Atrial natriuretic peptide-C receptor and membrane signalling in hypertension

Journal of Hypertension

Volumn 15, Issue 8, 1997, Pages 815-826

  Anand Srivastava, Madhu B ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adenylylcyclase; APN C receptor; Hypertension; MAP kinase; Phospholipase C

Indexed keywords

ADENYLATE CYCLASE; AMINO ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CYCLIC AMP; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 3; GUANYLATE CYCLASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE; RECEPTOR SUBTYPE;

BLOOD PRESSURE; CELL MEMBRANE; CELL PROLIFERATION; DNA SYNTHESIS; HUMAN; HYPERTENSION; KIDNEY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SPLEEN; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE; THYMUS; VASCULARIZATION;

EID: 0030752001     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715080-00004     Document Type: Review

References (134)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981, 288:89-94.
2. de Bold AJ: Atrial natriuretic factor of the rat heart Studies on isolation and properties. Proc Soc Exp Biol Med 1982, 170:133-138.
3. Anand-Srivastava MB, Franks DJ, Cantin M, Genest J: Atrial natriuretic factor inhibits adenylyl cyclase activity. Biochem Biophys Res Commun 1984, 121:855-862.
4. Anand-Srivastava MB, Cantin M, Genest J: Inhibition of pituitary adenylyl cyclase by atrial natriuretic factor. Life Sci 1985, 36:1873-1879.
5. Anand-Srivastava MB, Vinay P, Genest J, Cantin M: Effect of atrial natriuretic factor on adenylyl cyclase in various nephron segments. Am J Physiol 1986, 251:F417-F423.
6. Anand-Srivastava MB, Genest J, Cantin M: Inhibitory effect of atrial natriuretic factor on adenylyl cyclase activity in adrenal cortical membranes. FEBS Lett 1985, 181:199-202.
7. Anand-Srivastava MB, Cantin M: Atrial natriuretic factor receptors are negatively coupled to adenylyl cyclase in cultured atrial and ventricular cardiocytes. Biochem Biophys Res Commun 1986, 138:427-436.
8. Bianchi C, Anand-Srivastava MB, DeLean A, Gutkowska J, Forthomme D, Genest J, et al.: Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eye. Cutt Eye Res 1986, 5:283-293.
9. Hamet P, Tremblay J, Pang SC, Garcia R, Thibault G, Gutkowska J, et al.: Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun 1984, 123:515-527.
10. Waldman S, Rapport RM, Murad F: Atrial natriuretic factor selectively activates particulate guanylyl cyclase and elevates cGMP in rat tissues. J Biol Chem 1984, 259:15332-15334.
11. Winquist RJ, Farson EP, Waldman SA, Schwartz K, Murad F, Rapport RM: Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylyl cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 1984, 81:7661-7664.
12. Anand-Srivastava MB, Trachte GJ: Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 1993, 45:455-497.
13. Brenner BM, Ballarman BJ, Gunning ME, Zeidel ML: Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990, 70:665-699.
14. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988; 332:78-81.
15. Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990, 168:863-870.
16. Ruskoaho H: Atrial natriuetic eptide synthesis, release, and metabolism. Pharmacol Rev 1992, 44:479-602.
17. Stingo AJ, Clavell AL, Aarhus LL, Burnett JC: Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol 1992, 262:H308-H312.
18. Clavell AL, Stingo AJ, Wei CM, Heublein DM, Burnett JC: C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol 1993, 264:R290-R295.
19. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hawa N, et al.: Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of 'vascular natriuretic peptide system'. J Clin Invest 1992, 90:1145-1190.
20. Kambayashi Y, Nako K, Mukoyama M, Saito Y, Ogawa Y, Shiono S, et al.: Isolation and sequence determination of human brain natriuretic peptide inhuman atrium. FEBS Lett 1990, 259:341-345.
21. Chinkers M, Garbers DL, Chang M-S, Lowe DG, Chin H, Goeddel DV. et al.: A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989, 338:78-83.
22. Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, Garbers DL, et al.: Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J 1989, 8:1377-1384.
23. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, et al.: The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 1989, 58:1155-1162.
24. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV: Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclase. Nature 1989, 341:68-72.
25. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, et al.: Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem 1988, 263:9395-9401.
26. Anand-Srivastava MB, Srivastava AK, Cantin M: Pertussis-toxin attenuates atrial natriuretic factor-mediated inhibition of adenylate cyclase. Involvement of inhibitory guanine nucleotide regulatory protein. J Biol Chem 1987, 262:4931-4934.
27. Anand-Srivastava MB, Sairam MR, Cantin M: Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem 1990, 265:8566-8572.
28. Hirata M, Chang C-H, Murad F: Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovin aortic smooth muscle cells. Biochim Biophys Acta 1989, 1010:346-351.
29. Schenk DB, Phelps MN, Porter JG, Scarborough RM, McEnroe GA, Lewicki JA: Identification of the receptor for atrial natriuretic factor on cultured vascular cells. J Biol Chem 1985, 260:14887-14890.
30. Leitman DC, Andersen JW, Catalano RM, Waldman SA, Tuan JJ, Murad R: Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylyl cyclase activity in cultured cells. J Biol Chem 1988, 263:3720-3728.
31. Anand-Srivastava MB, Gutkoska J, Cantin M: The presence of atrialnatriuretic-factor receptors of ANF-R2 subtype in rat platelets. Biochem J 1991, 278:211-217.
32. Bianchi C, Thibault G, Wrobel-Konrad E, DeLean A, Genest J, et al.: Atrial natriuretic factor binding sites in experimental congestive heart failure. Am J Physiol 1989, 257:F515-F523.
33. Konrad EM, Bianchi C, Thibault G, Garcia R, Pelletier S, Genest J, Cantin M: Localization and characterization of binding sites for circulating and cerebroventricular atrial natriuretic factor in rat choroid plexus. Neuroendocrinology 1990, 51:304-314.
34. DeLean A, Gutkowska J, McNicoll N, Schiller PW, Cantin M, Genest J: Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. Life Sci 1984, 35:2311-2318
35. Ohashi M, Rujio N, Nawata H, Matsuo H, Kato K: Human atrial natriuretic polypeptide binding sites in human adrenal membrane fractions. Regul Pept 1988, 21:271-278.
36. Leitman DC, Andresen JW, Kuno T, Kamisaki Y, Chang J-K, Murad F: Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. J Biol Chem 1986, 261:11650-11655.
37. Schenk DB, Phelps MN, Porter JG, Fuller F, Cordell B, Lewicki JA: Purification and subunit composition of atrial natriuretic peptide receptor. Proc Natl Acad Sci USA 1987, 84:1521-1525.
38. Porter JG, Arfsten A, Fuller F, Miller JA, Gregory LC, Lewicki JA: Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem Biophys Res Commun 1990, 171:796-803.
39. Suzuki R, Takahashi A, Hazon N, Takei Y: Isolation of high-molecularweight C-type natriuretic peptide from the heart of a cartilaginous fish (European dogfish Scyliorhinus canicula). FEBS Lett 1991, 282:321-325.
40. Yamaguchi M, Rutledge LJ, Garbers DL: The primary structure of the rat guanylyl cyclase A/atrial natriuretic peptide receptor gene. J Biol Chem 1990, 265:20414-20420.
41. Nunez DJ, Dickson MC, Brown MJ: Natriuretic peptide receptor mRNAs in the rat and human heart J Clin Invest 1992, 90:1966-1971.
42. Saheki T, Mizuno T, Iwata T, Saito Y, Nagasawa T, Mixuno Ku, et al.: Structure of the bovine atrial natriuretic peptide receptor (type C) gene. J Biol Chem 1991, 266:11122-11125.
43. Kato J, Lanier-Smith KL, Currie MG: Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells. J Biol Chem 1991; 266:14681-14685.
44. Trachte GJ, Kanwal S, Elmquist BJ, Ziegler RJ: C-type natriuretic peptide neuromodulates via 'clearance' receptors. Am J Physiol 1995, 268:C978-C984.
45. Savoie P, de Champlain J, Anand-Srivastava MB: C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors. FEBS Lett 1995, 370:6-10.
46. Gilman AG: G-proteins and dual control of adenylate cyclase. Cell 1984, 36:577-579.
47. Gilman AG: G-proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987, 56:615-649.
48. Stryer L, Bourne HR: G-proteins: a family of signal transducers. Annu Rev Cell Biol 1986, 2:391-419.
49. Murakami T, Yasuda H: Rat heart cell membranes contain three substrates for cholera toxin-catalyzed ADP-ribosylation and a single substrate for cholera toxin-catalyzed ADP-ribosylation and a single substrate for pertussis toxin-catalyzed ADP-ribosylation. Biochem Biophys Res Commun 1986, 138:1355-1361.
50. Robishaw JD, Smigel MD, Gilman AG: Molecular basis for two forms of the G-protein that stimulates adenylyl cyclase. J Biol Chem 1986, 261:9587-9590.
51. Bray P, Caster A, Simons C, Guo V, Puckett C, Kamholz J, et al.: Human cDNA clones for four species of Gs signal transduction protein. Proc Natl Acad Sci USA 1986, 83:8893-8897.
52. Jones DT, Reed RR: Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J Biol Chem 1987, 262:14241-14249.
53. Itoh H, Toyama R, Kozasa T, Tsukamoto T, Matsuoka M, Kariro Y: Presence of three distinct molecular species of G, proteins alpha subunit. Structure of rat cDNAs and human genomic DNAs. J Biol Chem 1988, 263:6656-6664.
54. Cassel D, Pfeuffer T: Mechanism of cholera toxin action: covalent modification of the guanylyl nucleotide-binding protein of the adenylyl cyclase system. Proc Natl Acad Sci USA 1978, 75:2669-2672.
55. Hewlett EL, Cronin MI, Moss J, Anderson H, Myers GA, Pearson RD: Pertussis toxin: lessons from biological and biochemical effects in different cells. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984, 17:173-182.
56. Ui M: Islet-activating protein, pertussis-toxin: a probe for functions of inhibitory guanine nucleotide regulatory component of adenylyl cyclase. Trends Pharmacol Sci 1984, 5:277-279.
57. Kata T, Ui M: Islet-activating protein, a modifier of receptor-mediated regulation of rat islet adenylyl cyclase. J Biol Chem 1981, 256:8310-8317.
58. Katada T, Ui M: ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylyl cyclase activity. J Biol Chem 1982, 257:7210-7216.
59. Hazeki O, Ui M: Modification by islet-activating protein of receptor mediated regulation of cyclic AMP accumulation in isolated rat heart cells. J Biol Chem 1981, 256:2856-2862.
60. Neer EJ, Lok JM, Wolf LG: Purification and properties of the inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase. J Biol Chem 1984, 259:14222-14229.
61. Anand-Srivastava MB, Johnson RA, Picard S, Cantin M: Ninhibin: a sperm factor attenuates the atrial natriuretic factor-mediated inhibition of adenylyl cyclase: possible involvement of inhibitory guanine nucleotide regulatory protein. Biochem Biophys Res Commun 1985, 129:171-178.
62. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, et al.: Physiological role of silent receptors of atrial natriuretic factor. Science 1987, 238:675-678.
63. Tseng Y-C, Lahiri S, Sellitti DF, Burman KD, D'Avis JC, Wartofsky L: Characterization by affinity cross-linking of a receptor for atrial natriuretic peptide in cultured human thyroid cells associated with reductions in both adenosine 3′5′-monophosphate production and thyroglobulin secretion. J Clin Endocrinol Metab 1990, 7:528-533.
64. Koyama S, Terai T, Inoue T, Inomata K, Tamura K, Kobayashi Y, et al.: An oxidized analog of human atrial natriuretic polypeptide is a selective agonist for the atrial natriuretic polypeptide clearance receptor which lacks a guanylyl cyclase. Eur J Biochem 1992, 203:425-432.
65. Levin ER, Frank HJL: Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. Am J Physiol 1991, 261:R453-R457.
66. 2 in rabbit isolated vasa deferentia. J Pharmacol Exp Ther 1991, 256:720-726.
67. Cahill PA, Hassid A: Clearance receptor binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Biochem Biophys Res Commun 1991, 179:1606-1613.
68. Itoh H, Pratt RE, Ohno M, Dzau VJ: Atrial natriuretic polypeptpide as a novel antigrowth factor of endothelial cells. Hypertension 1992, 19:758-761.
69. Calderone A, Thaik CM, Takahashi N, Colucci WS: Norepinephrinestimulated DNA and protein synthesis are inhibited by nitric oxide and atrial natriuretic factor [abstract]. Circulation 1995, 92:1384.
70. Drewett JG, Ziegler RJ, Trachte GJ: Neuromodulatory effect of atrial natriuretic peptides correlate with an inhibition of adenylyate cyclase but not an activation of guanylyl cyclase. J Pharmacol Exp Ther 1992, 260:689-696.
71. Hu R-M, Levin ER, Pedram A, Frank HJL: Atrial natriuretic peptide inhibits the translation and secretion of endothelin from cultured bovine aortic endothelial cells: mediation through C receptors. J Biol Chem 1992, 267:17384-17389.
72. Aramori I, Nakanishi S: Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 1992, 267:12468-12474.
73. Lefkowitz PJ, Caron M: Adrenergic receptors. Models for the study of receptors coupled to guanine nucleotide regulatory proteins. J Biol Chem 1988, 263:4993-4996.
74. Okamoto T, Nishimoto I: Detection of G-protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem 1992, 267:8342-8346.
75. Strittmatter SM, Valenzucla D, Kennedy TE, Neer EJ, Fishman MC: Gs is a major growth cone protein subject to regulation by GAMP-43. Nature 1990, 344:836-841.
76. Higashijima T, Uzu S, Nakajima T, Ross EM: Mastoparam, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem 1988, 263:6491-6494.
77. Nishimoto I, Hata Y, Ogata E, Kojima I: Insulin-like growth factor Ii stimulates calcium influx in competent BALB/c 3T3 cells primed with epidermal growth factor. Characteristics of calcium influx and involvement of GTP-binding protein. J Biol Chem 1987, 262:12120-12126.
78. Nishimoto I, Murayama Y, Katada T, Ui M, Ogata E: Possible direct linkage of insulin-like growth factor II receptor with guanine nucleotide-binding proteins. J Biol Chem 1989, 264:14029-14038.
79. Rothenberg PL, Kahn CR Insulin inhibits pertussis toxin-catalyzed ADP-ribosylation of G-proteins. Evidence for a novel interaction between insulin receptors and G-proteins. J Biol Chem 1988, 263:15546-15552.
80. Anand-Srivastava MB, Sehl PD, Löwe DG: Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase: involvement of a pertussis toxin-sensitive G-protein. J Biol Chem 1996, 271:19324-19329.
81. Prins BA, Weber MJ, Hu R-M, Redram A, Daniels M, Levin ER: Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor: potential role in the inhibition of astrocyte proliferation. J Biol Chem 1996, 271:14156-14162.
82. Khalil F, Fine B, Kuriyama S, Hatori N, Nakamura M, Aviv A: Increased atrial natriuretic factor receptor density in cultured vascular smooth muscle cells of the spontaneously hypertensive rats. Clin Exp Theory Practice [A] 1987, 9:741-752.
83. Resink TJ, Scott-Burden, T, Jones CR, Baur U, Buhler FR: Atrial natriuretic peptide: binding and cyclic GMP responses in cultures vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens 1989, 2:32-39.
84. Nakamura M, Nakamura A, Fine B, Aviv A: Blunted cGMP response to ANF in vascular smooth muscle cells of SHR. Am J Physiol 1988, 255:C573-C580.
85. Sauro MD, Fitzpatrick DF, Coffey RG: Defective cyclic GMP accumulation in spontaneously hypertensive rat aorta in response to atrial natriuretic factor. Biochem Pharmacol 1988, 37:2109-2112.
86. Cachofeiro V, Schiffrin EL, Thibault G, Cantin M, Garcia R: Effect of a chronic infusion of atrial natriuretic factor on glomerular and vascular receptors in spontaneously hypertensive rats. J Hypertens 1989, 7:335-342.
87. Tremblay J, Huot C, Willenbrock RC, Bayard F, Gossard F, Jujio N, et al.: Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. J Clin Invest 1993, 92: 2499-2508.
88. Schiffrin EL: Vascular receptors for angiotensin, vasopressin, and atrial natriuretic peptide in experimental hypertension. Can J Physiol Pharmacol 1989, 67:1118-1123.
89. Nuglozeh E, Gauquelin G, Garcia R, Tremblay J, Schiffrin EL: Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats. Am J Physiol 1990, 259:F130-F137.
90. Anand-Srivastava MB: Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats: relationship to adenylyl cyclase inhibition. Biochem J 1992, 288:79-85.
91. Anand-Srivastava MB, de Champlain J, Thibault C: DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am J Hypertens 1993, 6:72-75.
92. Pandey SK, Anand-Srivastava MB: Modulation of G-protein expression by angiotensin converting enzyme inhibitor captopril in hearts from spontaneously hypertensive rats: relationship with adenylyl cyclase. Am J Hypertens 1996, 9:833-837.
93. Garcia R, Gauquelin G, Thibault G, Cantin M, Schiffrin EL: Glomerular atrial natriuretic factor in spontaneously hypertensive rats. Hypertension 1989, 13:567-574.
94. Saito H, Inui K, Matsukawa Y, Okano T, Maegawa H, Nakao K, et al.: Specific binding of atrial natriuretic polypeptide to renal basolateral membranes in spontaneously hypertensive rats (SHR) and strokeprone SHR. Biochem Biophys Res Commun 1986, 137:1079-1085.
95. Ogura T, Mitsui T, Yamamoto I, Katayama E, Ota Z, Ogawa N: Differential changes in atrial natriuretic peptide and vasopressin receptor binding in kidney of spontaneously hypertensive rats. Life Sci 1987, 40:233-238.
96. Gauquelin G, Schiffrin EL, Cantin M, Garcia R: Specific binding of atrial natriuretic factor to renal glomeruli in DOCA and DOCA-salt treated rats: correlation with atrial and plasma concentrations. Biochem Biophys Res Commun 1997, 145:522-531.
97. Takatori K, Ogura T, Ota Z: Computerized approach using autoradiography to quantify atrial natriuretic peptide receptors in DOCA-salt hypertensive kidney. Regulatory Peptides 1991, 35:115-125.
98. Gauquelin G, Garcia R, Schiffrin EL, Carrier F, Thibault G, Cantin M, et al.: Renal glomerular ANF receptor in renovascular hypertension in the rat. Arch Mal Cœur 1987, 80:966-969.
99. Garcia R, Gauquelin G, Cantin M, Schiffrin EL: Renal glomerular atrial natriuretic factor receptors in one kidney, one clip rats. Hypertension 1988, 11:185-190.
100. Shionoiri H, Hirawa N, Takasaki I, Ishikawa Y, Oda H, Minamisawa K-S, et al.: Functional atrial natriuretic peptide receptor in human adrenal tumor. J Cardiovasc Pharmacol 1989, 13:S9-S12.
101. Saavedra JM, Castren E, Gutkind JS, Nazarah AJ: Regulation of brain atrial natriuretic peptide and angiotensin receptors: quantitative autoradiographic studies, Int Rev Neurobiol 1989, 31:257-296.
102. McCarty R, Plunkett LM: Forebrain binding sites for atrial natriuretic factor: alterations in spontaneously hypertensive (SHR) rats. Neurochem Int 1986, 9:177-183.
103. Brown J, Czarnecki A: Receptor subtypes for atrial natriuretic peptides in the brains of hypertensive rats. Am J Physiol 1991, 260:R441-R447.
104. McCarty R, Plunkett LM: Binding sites for atrial natriuretic factor in brain: alterations in Brattleboro rats. Brain Res Bull 1986, 17:767-772.
105. Stewart RE, Switters SE, McCarty R: Alterations in binding sites for atrial natriuretic factor (ANF) in kindeys and adrenal glands of Dahl hypertensive-sensitive (S/JR) rats. J Hypertens 1987, 5:481-487.
106. Okazaki M, Kobayashi H, Kuroiwa A, Izumi F: Atrial natriuretic peptide receptors in cerebral microvessels and choroid plexus of spontaneously and hypertensives rats. Brain Res 1990, 518:292-294.
107. Gutkind JS, Kurihara M, Castren E, Saavedra JM: Atrial natriuretic peptide receptors in sympathetic ganglia: biochemical response and alterations in genetically hypertensive rats. Biochem Biophys Res Commun 1987, 149:65-72.
108. Anand-Srivastava MB: Spontaneously hypertensive rats (SHR) exhibit altered expression of G-proteins in brain striatum. Pharmacologist 1992, 34: 141.
109. Schiffrin EL, Deslongchamps M, Thibault G: Platelet binding sites for atrial natriuretic factor in humans. Hypertension 1986, 8 (suppl II):II6-II10.
110. Duggan J, Kilfeather S, Lightman SL, O'Brien E, O'Malley K: Plasma atrial natriuretic peptide concentration and platelet atrial natriuretic peptide binding site density in ageing and hypertension. Clin Sci 1991, 81:509-514.
111. Anand-Srivastava MB: Platelets from spontaneously hypertensive rats exhibit decreased expression of inhibitory guanine nucleotide regulatory protein: relation with adneylyl cyclase activity. Circ Res 1993, 73:1032-1039.
112. Marcil J, Schiffrin EL, Anand-Srivastava MB: Aberrant adenylyl cyclase/cAMP signal transduction and G-protein levels in platelets from hypertensive patients improve with antihypertensive drug therapy. Hypertension 1996, 28:83-90.
113. 2 receptors coupled to adenylyl cyclase in cardiovascular tissues in hypertension. Am J Hypertens 1993, 6:538-541.
114. Schiffrin EL, Carrier F, Thibault G, Deslongchamps M: Solubilization and molecular characterization of the atrial natriuretic peptide (ANP) receptor in human platelets: comparison with ANP receptors in rat tissues. J Clin Endocrinol Metab 1991, 72:484-491.
115. Khurihara M, Castren E, Gutkind JS, Saavedra JM: Lower number of atrial natriuretic peptide receptors in thymocytes and spleen cells of spontaneously hypertensive rats. Biochem Biophys Res Commun 1987, 149:1132-1140.
116. Marcil J, Anand-Srivastava MB: Defective ANF-R2/ANP-C receptormediated signalling in hypertension. Mol Cell Biochem 1995, 149/150:223-231.
117. Chang GE, Anand-Srivastava MB: Altération des protéines G et de l'activité adénylyl cyclase dans le cœur du rat hypertendu par clampage d'une artère rénale (1K-1C) [abstract]. Médecine Sciences 1996, 12 (suppl 2).
118. Marcil J, Anand-Srivastava MB: Enhanced expression of Gi protein precedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol 1997, 27:1009-1022.
119. Marcil J, de Champlain J, Anand-Srivastava MB: Altération de l'expression et de la fonction des protéines G dans les tissus cardiovasculaires des rate DOCA-sel hypertendus [abstract]. Médecine-Sciences 1995, 11:10.
120. 1 guanylyl cyclase and intraoccular pressure in the rabbit eye. Curr Eye Res 1987, 6:1189-1196.
121. Resink T, Pauchenko MP, Tkachuk VA, Buhler FR: Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylyl cyclase in rat lung plasma membranes. Eur J Biochem 1988, 174:531-535.
122. Anand-Srivastava MB: Characterization of ANF-R2 receptor-mediated inhibition of adenylyl cyclase. Mol Cell Biochem 1992, 6:83-92.
123. Katafuchi T, Mizuno T, Hagiwara H, Itakura M, Ito T, Hirose S: Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells. J Biol Chem 1992, 267:7624-7629.
124. Chabrier PE, Roubert P, Lonchamp MO, Bias P, Braquet P: Regulation of atrial natriuretic factor receptors by angiotensin II in rat vascular smooth muscle cells. J Biol Chem 1988, 263:13199-13202.
125. Hirata Y, Takata S, Takagi Y, Matsukara H, Omae T: Regulation of atrial natriuretic peptide receptors in cultured vascular smooth muscle cells of rat Biochem Biophys Res Commun 1986, 138:405-412.
126. Smith-Bingham J, Lincoln T: Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am J Physiol 1987, 253:C147-C150.
127. 2 receptors [abstract]. Hypertension 1989, 14:347.
128. Schiffrin EL, Turgeon A, Tremblay J, Deslongchamps M: Effects of ANP, angiotensin, vasopressin and endothelin on ANP receptors in cultured vascular smooth muscle cells. Am J Physiol 1991, 260:H48-H65.
129. 2/ANP-C receptors by angiotensin II in vascular smooth muscle cells. Am J Hypertens 1996, 9:930-934.
130. Schiffrin EL, Poissant L, Cantin M, Thibault G: Receptors for atrial natriuretic factor in cultured vascular smooth muscle cells. Life Sci 1986, 38:817-826.
131. Martin ER, Lewicki JA, Scarborough RM, Bellerwan BJ: Expression and regulation of ANP receptor subtypes in rat renal glomeruli and papillae. Am J Physiol 1989, 257:F649-F657.
132. Anand-Srivastava MB, Palaparti A, Pion J: Differential regulation of G-protein expression by vasoactive peptides. Mol Cell Biochem 1997:21-27.
133. Agui T, Xin X, Cai Y, Shim G, Muramatsu Y, Yamada T, et al.: Opposite actions of transforming growth factor-beta 1 on the gene expression of atrial natriuretic peptide biological and clearance receptors in a murine thymic stromal cell line. J Biochem 1995, 118:500-507.
134. Kishimoto E, Yoshimasa T, Suga S, Ogawa Y, Komatsu Y, Nakagawa O, et al.: Natriuretic peptide clearance receptor is transcriptionally down regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells. J Biol Chem 1994, 269:28300-28308.